Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Case Number
Disposition
Attorney(S)
Judges
Acts
  • Item 92 of the Schedule to the Act
  • Section 21 of the Act
  • Section 20(b)(i) read with Section 8 of the Narcotic Drugs and Psychotropic Substances Act, 1985
  • the Act (which is a list of psychotropic substances)
  • Section 8 of the Act
  • Section 9 of the Act
  • Section 20 of the Act
  • Section 2(xi) of the Act
  • Section 27 of the Act
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Case Number
Disposition
Attorney(S)
Judges
Acts
  • Item 92 of the Schedule to the Act
  • Section 21 of the Act
  • Section 20(b)(i) read with Section 8 of the Narcotic Drugs and Psychotropic Substances Act, 1985
  • the Act (which is a list of psychotropic substances)
  • Section 8 of the Act
  • Section 9 of the Act
  • Section 20 of the Act
  • Section 2(xi) of the Act
  • Section 27 of the Act
Smart Summary

Factual and Procedural Background

The appellant was found on 25 June 1994 in possession of six ampoules of “Buprenorphine tidigesic” (2 ml each) and two syringes. He did not dispute possession, asserting that he used the drug under medical advice and produced a doctor (DW 1) in support. The Sessions Court treated the substance as a “manufactured drug” under the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) and, under Section 20(b)(i) read with Section 8, convicted him, imposing ten years’ rigorous imprisonment and a fine of ₹1,00,000. The High Court dismissed his appeal and confirmed the conviction and sentence. The appellant thereafter filed the present appeal before the Supreme Court of India, which appointed successive amicus curiae and ultimately reheard the matter with the assistance of the Additional Solicitor General for the State of Kerala.

Legal Issues Presented

  1. Whether “Buprenorphine tidigesic” qualifies as a “manufactured drug” under Section 2(xi) of the NDPS Act, thereby attracting Section 21 liability.
  2. If not a manufactured drug, whether possession of six ampoules of Buprenorphine—listed as a psychotropic substance—constitutes an offence under Section 8 of the NDPS Act read with Rule 66 of the NDPS Rules, 1985.
  3. Whether the conviction and sentence imposed by the Sessions Court and affirmed by the High Court were legally sustainable.

Arguments of the Parties

The opinion does not contain a detailed account of the parties' legal arguments.

Table of Precedents Cited

No precedents were cited in the provided opinion.

Court's Reasoning and Analysis

The Supreme Court first examined the classification of Buprenorphine. It noted that the prosecution had failed to demonstrate that the substance fell under any of the categories in the first limb of the “manufactured drug” definition in Section 2(xi) of the NDPS Act, nor was any Government notification produced to invoke the second limb. Consequently, treating Buprenorphine as a manufactured drug under Section 21 was erroneous.

The Court then identified Buprenorphine as a “psychotropic substance,” relying on Item 92 of the Schedule to the Act, added by notification dated 26 October 1992. Possession of a psychotropic substance becomes punishable only if it contravenes Section 8, which prohibits possession except for medical or scientific purposes as regulated by the Act, Rules, or orders.

Under Rule 66(2) of the NDPS Rules, an individual is permitted to possess up to 100 dosage units of a psychotropic substance for personal medical use. The Court found no evidence that six ampoules exceeded this statutory limit or that the appellant’s possession was otherwise unauthorized. It emphasized that neither the doctor (DW 1) nor the District Medical Officer (Court Witness 1) suggested that six ampoules surpassed 100 dosage units.

Because the possession fell within the permissible quantity and was ostensibly for medical use, the Court concluded that the appellant’s conduct did not contravene Section 8. The conviction and sentence, therefore, lacked legal sanction and resulted in the appellant’s unlawful incarceration for five years.

Holding and Implications

Appeal Allowed; Conviction and Sentence Quashed; Appellant Acquitted. The Court directed that the appellant be released forthwith. Although it declined to award compensation, it expressly preserved the appellant’s right to seek such relief through appropriate legal channels.

Implications: The decision reaffirms that possession of a psychotropic substance within the 100-dosage-unit limit for personal medical use, as permitted under Rule 66(2) of the NDPS Rules, does not constitute an offence under the NDPS Act. The ruling primarily impacts the parties involved and clarifies statutory compliance without creating new precedent beyond the application of existing rules.

To access the original judgment, please Sign In or Subscribe.

    Hussain v. State Of Kerala .

    K.T Thomas, J.— This seems to be a very unfortunate case in which the appellant by his fatality had languished in jail already for a long period of 5 years, when as a matter of law he should have been moving about as a free citizen. Appellant in this case was charged by the Sessions Court with an offence under Section 20(b)(i) read with Section 8 of the Narcotic Drugs and Psychotropic Substances Act, 1985 (for short “the Act”). He was sentenced to undergo rigorous imprisonment for 10 years and to pay a fine of Rs 1,00,000. He filed an appeal before the High Court and a learned Single Judge who heard the appeal confirmed the conviction and sentence and dismissed his appeal. He filed this appeal by special leave from jail.

    2. The misfortune hovering around him continued to persist as the counsel appointed as amicus curiae to argue for him did not turn up and we had to remove him as amicus curiae. We appointed another counsel (Mr Bimal Roy Jad) as amicus curiae. On 11-8-1999 we heard him and the learned counsel for the State in detail and reserved the judgment. Thereafter we felt that the appeal should be reheard as certain new features have emerged while contemplating the factual position in this case. We, therefore, reposted the matter. Today we are assisted by Shri Altaf Ahmad, learned Additional Solicitor General who argued for the State of Kerala, though Mr Bimal Roy Jad has not turned up to argue for the appellant, nor did he make any representation.

    3. The factual matrix as revealed in the judgment of the trial court and the High Court is this:

    On 25-6-1994 the appellant was found in possession of 6 ampoules of “Buprenorphine tidigesic” each containing 2 ml. He was also found in possession of 2 syringes each of 5 ml capacity. It is pertinent to point out that the appellant, unusually, did not dispute that the aforesaid substance had been recovered from him. On the contrary he said that he was regularly using it under medical advice. He examined a Doctor as DW 1 to say that a prescription was administered by him to the appellant for using the aforesaid substance as a medical formulation. The trial court after completing prosecution evidence and the defence evidence has proceeded to examine the District Medical Officer as Court Witness 1 in order to ascertain whether the quantity of substance recovered from the appellant would fall within the limit of “small quantity” envisaged in Section 27 of the Act. Having found that the quantity recovered from the appellant has exceeded the limit of “small quantity” the trial court proceeded to consider whether the offence charged against him was made out.

    4. Section 20 deals with contravention in relation to cannabis plant and cannabis. As the article recovered from the appellant cannot fall within the ambit of either cannabis plant or cannabis the court had slipped down to Section 21 which relates to contravention of the law in respect of “manufactured drugs and preparations”. As the District Medical Officer opined that “Buprenorphine tidigesic” is a manufactured drug the trial court proceeded on that premise and found him guilty under Section 21 of the Act and convicted him and sentenced him as aforesaid.

    5. “Manufactured drug” is defined in Section 2(xi) of the Act, which reads thus:

    “2. (xi) ‘manufactured drug’ means—
    (a) all coca derivatives, medicinal cannabis, opium derivatives and poppy straw concentrate;
    (b) any other narcotic substance or preparation which the Central Government may, having regard to the available information as to its nature or to a decision, if any, under any international convention, by notification in the Official Gazette, declare to be a manufactured drug,
    but does not include any narcotic substance or preparation which the Central Government may, having regard to the available information as to its nature or to a decision, if any, under any international convention, by notification in the Official Gazette, declare not to be a manufactured drug;”

    6. No attempt has been made to show that “Buprenorphine tidigesic” would fall within the 1st limb of the definition: As no notification published by the Central Government in the Official Gazette has been brought to the notice of the Court there is no question of considering whether the said article would fall within the 2nd limb of the definition. So, the prosecution has totally failed to prove that the substance was a manufactured drug falling within the aforesaid definition.

    7. It is unnecessary for us to consider whether the said substance is a narcotic drug as defined in the Act, for, it is easily discernible from Item 92 of the Schedule to the Act (which is a list of psychotropic substances) that “Buprenorphine” is a psychotropic substance. We may point out that the aforesaid Item 92 had been added to the list of psychotropic substances by the notification dated 26-10-1992. The offence in this case is alleged to have been committed on 25-6-1994. We have therefore, no doubt that the substance recovered from the appellant is a psychotropic substance.

    8. If it was “psychotropic substance” possession of the same would amount to an offence only if it was in contravention of Section 8 of the Act. That section shows that no person shall possess any psychotropic substance except for medical or scientific purposes and in the manner and to the extent provided by the provisions of this Act or the Rules or orders made thereunder.

    9. Section 9 of the Act empowers the Central Government to permit, control and regulate the cultivation, production, possession etc. of psychotropic substances. Rules have been formulated by the Central Government under that power. Rule 66 falling under Chapter VII of the Rules is important and hence the same is extracted below:

    “66. Possession, etc., of psychotropic substances.—(1) No person shall possess any psychotropic substance for any of the purposes covered by the 1945 Rules, unless he is lawfully authorised to possess such substance for any of the said purposes under these Rules.
    (2) Notwithstanding anything contained in sub-rule (1), any research institution, or a hospital or dispensary maintained or supported by Government or local body or by charity or voluntary subscription, which is not authorised to possess any psychotropic substance under the 1945 Rules, or any person who is not so authorised under the 1945 Rules, may possess a reasonable quantity of such substance as may be necessary for their genuine scientific requirements or genuine medical requirements, or both for such period as is deemed necessary by the said research institution or, as the case may be, the said hospital or dispensary or person:
    Provided that where such psychotropic substance is in possession of an individual for his personal medical use the quantity thereof shall not exceed one hundred dosage units at a time.
    (3) The research institution, hospital and dispensary referred to in sub-rule (2) shall maintain proper accounts and records in relation to the purchase and consumption of the psychotropic substance in their possession.”

    10. The proviso to sub-rule (2) is very evident that a person is permitted to keep in his possession for his personal medical use the psychotropic substance up to one hundred dosage at a time.

    11. We are not disposed to think that 6 ampoules would cross the above limit and there is no attempt made either through DW 1 (Doctor) or through Court Witness 1 (DMO) that 100 dosage would be below the 6 ampoules recovered from him.

    12. It is unfortunate that the aforesaid points have not been put forward before the trial court or the High Court. We feel that the conviction and sentence imposed on this appellant were without the sanction of law. The appellant is unlawfully deprived of his personal liberty for such a long period of 5 years on account of overlooking the aforesaid facts and the legal position.

    13. We, therefore, allow this appeal and quash the judgment of the High Court as well as the Sessions Court. We acquit the appellant and direct him to be set at liberty forthwith. In this case, we are not considering the question of awarding compensation to the appellant but he is free to resort to his remedies under law for that purpose.

    Use AI to get other relevant cases.

    Comments

    Hussain v. State Of Kerala .
    (Oct 27, 1999)